| abstract |
Disclosed are azole compounds comprising carbamoyl groups and pharmaceutically useful salts thereof. The compounds may be of central nervous system diseases, particularly anxiety, depression, convulsions, epilepsy, migraine, bipolar disorder, drug abuse, smoking, ADHD, obesity, sleep disorders, neuroapthic pain, stroke, cognitive impairment It is an effective anticonvulsant agent used in the treatment of neurodegeneration and muscle spasms. |